EUVIMEDEUVIMED entdecken
Open Access

RIBOTAC-mediated degradation of hsa-microRNA-301a-3p suppresses TNBC bone metastasis

Wei Zhou iD, Jinmei Jin iD, Xiao-Hui Liang iD, Yue Yan iD, Qingyi Xiong iD, Dong Lu iD, Hongzhuan Chen iD, Ye Wu iD, Wei-Dong Zhang iD, Xin Luan iD

Science Advances · 2026

DOI: 10.1126/sciadv.aeh7999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Wei Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200025, China. Hauptthemen laut MEDLINE: MicroRNAs, Bone Neoplasms, Triple Negative Breast Neoplasms, Endoribonucleases. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National key R&D program of China, National Natural Science Foundation of China, Shanghai Shuguang Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive subtype with a high propensity for bone metastasis and limited treatment options. Although many proteins drive metastasis, most remain inaccessible to conventional small-molecule drugs due to lack of suitable binding sites, prompting interest in upstream RNA regulators. Using integrative bioinformatics and machine learning, we identified hsa-microRNA-301a-3p as a central regulator of TNBC bone metastasis. However, current nucleic acid–based therapies are limited by instability and inefficient delivery. To overcome these challenges, we designed a ribonuclease-targeting chimera (RIBOTAC) that recruits endogenous RNase L to degrade the primary transcript pri-microRNA-301a. The resulting RIBOTAC efficiently reduced hsa-microRNA-301a-3p levels, restored NEDD4L expression, and promoted degradation of the oncogenic protein YAP, thereby suppressing TNBC bone metastasis. These findings identify hsa-microRNA-301a-3p as a key driver and demonstrate RNA-targeted degradation as a therapeutic strategy in TNBC bone metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBone NeoplasmsTriple Negative Breast NeoplasmsEndoribonucleasesHumansFemaleCell Line, TumorGene Expression Regulation, NeoplasticAnimalsNedd4 Ubiquitin Protein LigasesMice

Substanzen

MicroRNAsMIRN301A microRNA, humanEndoribonucleasesNedd4 Ubiquitin Protein Ligases

Autor:innen und Institutionen

  • School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200025, China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine…
  • State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100700, China.
  • School of Pharmacy, Naval Medical University, Shanghai, 200433, China.

ORCID-Profile: Wei Zhou, Jinmei Jin, Xiao-Hui Liang, Yue Yan, Qingyi Xiong, Dong Lu, Hongzhuan Chen, Ye Wu, Wei-Dong Zhang, Xin Luan

Förderung

  • National key R&D program of China
  • National Natural Science Foundation of China
  • Shanghai Shuguang Program
  • Shanghai Sailing Program
  • CAMS Innovation Fund for Medical Sciences
  • Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources
  • Innovative Drug Research and Development-National Science and Technology Major Project
  • High level Key Discipline of National Administration of Traditional Chinese Medicine

Zitieren

APA

Zhou, W., Jin, J., Liang, X. H., Yan, Y., Xiong, Q., Lu, D., Chen, H., Wu, Y., Zhang, W. D., & Luan, X. (2026). RIBOTAC-mediated degradation of hsa-microRNA-301a-3p suppresses TNBC bone metastasis. Science Advances. https://doi.org/10.1126/sciadv.aeh7999

Vancouver

Zhou W, Jin J, Liang XH, Yan Y, Xiong Q, Lu D, et al. RIBOTAC-mediated degradation of hsa-microRNA-301a-3p suppresses TNBC bone metastasis. Science Advances. 2026. doi:10.1126/sciadv.aeh7999

BibTeX
@article{Zhou2026,
  author = {Zhou, Wei and Jin, Jinmei and Liang, Xiao-Hui and Yan, Yue and Xiong, Qingyi and Lu, Dong and Chen, Hongzhuan and Wu, Ye and Zhang, Wei-Dong and Luan, Xin},
  title = {RIBOTAC-mediated degradation of hsa-microRNA-301a-3p suppresses TNBC bone metastasis},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeh7999}
}
Kostenlos starten →